{"transactions":[{"id":1701928,"issuer":{"id":8005,"kind":"organization","name":"Zeo ScientifiX, Inc."},"owners":[{"id":95917,"kind":"person","name":"Leider Harry L.","position":1,"cik":"0001888273","reported_name":"Leider Harry L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-21T21:01:40.000Z","date":"2023-06-29","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":0.01,"value":5000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. The purpose of this Amendment is to correct the purchase price for the shares purchased on June 28, 2023."}],"balance_after":1049450,"source":{"system":"sec-edgar","filing":"0001829126-23-008158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623008158/ownership.xml","form_type":"4/A","original_submission_date":"2023-06-30"}},{"id":1701927,"issuer":{"id":8005,"kind":"organization","name":"Zeo ScientifiX, Inc."},"owners":[{"id":95917,"kind":"person","name":"Leider Harry L.","position":1,"cik":"0001888273","reported_name":"Leider Harry L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-21T21:01:40.000Z","date":"2023-06-28","kind":"purchase","planned":false,"acquired":true,"shares":549450,"price":0.0099,"value":5439.555,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. The purpose of this Amendment is to correct the purchase price for the shares purchased on June 28, 2023."}],"balance_after":549450,"source":{"system":"sec-edgar","filing":"0001829126-23-008158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623008158/ownership.xml","form_type":"4/A","original_submission_date":"2023-06-30"}},{"id":1703170,"issuer":{"id":8005,"kind":"organization","name":"Zeo ScientifiX, Inc."},"owners":[{"id":95917,"kind":"person","name":"Leider Harry L.","position":1,"cik":"0001888273","reported_name":"Leider Harry L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-20T21:05:26.000Z","date":"2023-12-19","kind":"sale","planned":false,"acquired":false,"shares":5248,"price":1.315,"value":6901.12,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares disposed of were held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001829126-23-008139","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623008139/ownership.xml","form_type":"4"}},{"id":1840837,"issuer":{"id":8005,"kind":"organization","name":"Zeo ScientifiX, Inc."},"owners":[{"id":95917,"kind":"person","name":"Leider Harry L.","position":1,"cik":"0001888273","reported_name":"Leider Harry L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-30T20:05:14.000Z","date":"2023-06-29","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":0.01,"value":5000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee."}],"balance_after":1049450,"source":{"system":"sec-edgar","filing":"0001829126-23-004521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623004521/ownership.xml","form_type":"4"}},{"id":1840836,"issuer":{"id":8005,"kind":"organization","name":"Zeo ScientifiX, Inc."},"owners":[{"id":95917,"kind":"person","name":"Leider Harry L.","position":1,"cik":"0001888273","reported_name":"Leider Harry L.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-30T20:05:14.000Z","date":"2023-06-28","kind":"purchase","planned":false,"acquired":true,"shares":549450,"price":0.099,"value":54395.55,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee."}],"balance_after":549450,"source":{"system":"sec-edgar","filing":"0001829126-23-004521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912623004521/ownership.xml","form_type":"4"}},{"id":2277792,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":95917,"kind":"person","name":"Leider Harry L.","position":1,"cik":"0001888273","reported_name":"Leider Harry L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-09T16:17:59.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":269660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares underlying this option shall vest and become exercisable on March 4, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."}],"balance_after":269660,"derivative":{"exercise_price":3.33,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":269660},"source":{"system":"sec-edgar","filing":"0001104659-22-057537","document":"tm2214815d8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000110465922057537/tm2214815d8_4seq1.xml","form_type":"4"}},{"id":2277791,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":95917,"kind":"person","name":"Leider Harry L.","position":1,"cik":"0001888273","reported_name":"Leider Harry L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-05-09T16:17:59.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":269660,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement."},{"field":"shares","element":"transactionShares","label":"F4","text":"25% of these RSUs shall vest on April 1, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement."}],"balance_after":314090,"source":{"system":"sec-edgar","filing":"0001104659-22-057537","document":"tm2214815d8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000110465922057537/tm2214815d8_4seq1.xml","form_type":"4"}},{"id":2277790,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":95917,"kind":"person","name":"Leider Harry L.","position":1,"cik":"0001888273","reported_name":"Leider Harry L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-05-09T16:17:59.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":34266,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement."},{"field":"shares","element":"transactionShares","label":"F3","text":"These RSUs vest in full on February 15, 2023, subject to the reporting person's continued service at such time."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement."}],"balance_after":44430,"source":{"system":"sec-edgar","filing":"0001104659-22-057537","document":"tm2214815d8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000110465922057537/tm2214815d8_4seq1.xml","form_type":"4"}},{"id":2277789,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":95917,"kind":"person","name":"Leider Harry L.","position":1,"cik":"0001888273","reported_name":"Leider Harry L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-05-09T16:17:59.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":10164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement."},{"field":"shares","element":"transactionShares","label":"F2","text":"These RSUs vest in full on February 8, 2023, subject to the reporting person's continued service at such time."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement."}],"balance_after":10164,"source":{"system":"sec-edgar","filing":"0001104659-22-057537","document":"tm2214815d8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000110465922057537/tm2214815d8_4seq1.xml","form_type":"4"}}]}